A detailed history of Securian Asset Management, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Securian Asset Management, Inc holds 18,627 shares of MRNA stock, worth $740,795. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,627
Previous 19,086 2.4%
Holding current value
$740,795
Previous $2.27 Million 45.1%
% of portfolio
0.04%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $29,210 - $57,439
-459 Reduced 2.4%
18,627 $1.24 Million
Q2 2024

Jul 15, 2024

SELL
$101.21 - $166.61 $44,228 - $72,808
-437 Reduced 2.24%
19,086 $2.27 Million
Q1 2024

Apr 26, 2024

SELL
$85.37 - $115.44 $121,822 - $164,732
-1,427 Reduced 6.81%
19,523 $2.08 Million
Q4 2023

Feb 08, 2024

SELL
$69.51 - $104.43 $189,762 - $285,093
-2,730 Reduced 11.53%
20,950 $2.08 Million
Q3 2023

Oct 30, 2023

SELL
$96.41 - $126.61 $363,080 - $476,813
-3,766 Reduced 13.72%
23,680 $2.45 Million
Q2 2023

Aug 07, 2023

SELL
$118.5 - $160.53 $62,212 - $84,278
-525 Reduced 1.88%
27,446 $3.33 Million
Q1 2023

Apr 27, 2023

BUY
$135.66 - $197.02 $5,562 - $8,077
41 Added 0.15%
27,971 $4.3 Million
Q4 2022

Feb 02, 2023

SELL
$118.38 - $210.04 $76,355 - $135,475
-645 Reduced 2.26%
27,930 $5.02 Million
Q3 2022

Oct 28, 2022

SELL
$118.07 - $194.18 $83,003 - $136,508
-703 Reduced 2.4%
28,575 $3.38 Million
Q2 2022

Aug 04, 2022

SELL
$117.13 - $176.59 $77,422 - $116,725
-661 Reduced 2.21%
29,278 $4.18 Million
Q1 2022

May 03, 2022

SELL
$126.46 - $235.05 $67,782 - $125,986
-536 Reduced 1.76%
29,939 $5.16 Million
Q4 2021

Feb 10, 2022

BUY
$225.82 - $368.51 $108,393 - $176,884
480 Added 1.6%
30,475 $7.74 Million
Q3 2021

Nov 08, 2021

BUY
$221.9 - $484.47 $6.66 Million - $14.5 Million
29,995 New
29,995 $11.5 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.